Postmarketing Surveillance Study of OxyContin® Tablets for Relieving Moderate to Severe Postherpetic Neuralgia Pain

By  

Oncology, Vol. 74, Iss. 1, 2008-08 ,pp. : 66-71

Karger

Access to resources Recommend Favorite

Epidemiological data, efficacy and safety of a paracetamol––tramadol fixed combination in the treatment of moderate-to-severe pain. SALZA: a post-marketing study in general practice

By Mejjad O.   Serrie A.   Ganry H.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1013-1020

Informa Healthcare

Access to resources Recommend Favorite

Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland

By Przeklasa-Muszynska Anna   Dobrogowski Jan  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1109-1117

Informa Healthcare

Access to resources Recommend Favorite

FDA approves OxyContin for certain pediatric patients

By  

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 17, Iss. 10, 2015-10 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves OxyContin for certain pediatric patients

By  

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 1527-8395, Iss. 10, 2015-10 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite